Paradromics Inc., a brain implant rival to Elon Musk’s Neuralink Corp., is partnering with Saudi Arabia’s Neom to develop brain-computer interface therapies in the Middle East and North Africa.

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

"The Miami Project and the University of Miami are renowned for their pioneering research in neural interfaces for the treatment of debilitating neurological conditions," Neuralink co-founder and COO ...

A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

Neuralink is celebrating its first year of "Telepathy" involving human trials with its innovative brain-computer interface, ...

A national study led by the University of Bristol has revealed that both the public and divorcees themselves have limited knowledge about the leg ...

On Wednesday, Jan. 29, the Woodland Park School District voted to reject gender ideology and only recognize two sexes ...

CoinDCX is launching Bitcoin Chai Cafes at popular tea stalls near financial hubs and tech parks in India to educate people about Bitcoin. These cafes will use engaging decor and trivia to make ...

OpenAI CEO Sam Altman recognized the rise of new AI competitor DeepSeek and its model DeepSeek R1. He praised DeepSeek's pricing strategy and emphasized OpenAI's ongoing commitment to developing ...

The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine is the second site in the U.S. to partake in the brain-chip clinical trial of Elon Musk’s Neuralink company.

Miller School of Medicine is the second U.S. site to join Neuralink's PRIME study, according to a Jan. 27 news release. The investigational medical device clinical trial is assessing the safety and ...